We have previously reported that, depending on their activation status, mouse gd T cells can either enhance or inhibit the activity of IL-17 + autoreactive T cells in experimental autoimmune uveitis. In this study, we showed that gd T cells in naive C57BL/6 (B6) mouse do not express the IL-23R, whereas in immunized mice, it is expressed on >50% of gd T cells. In vitro studies showed that IL-23R expression on gd T cells is modulated by their state of activation, as weakly activated gd T cells expressed the IL-23R, but highly activated gd T cells did not. Functional studies showed that IL-23R + gd T cells had the strongest suppressive effect on IL-17 + autoreactive T cells, and that this effect was inhibited when the IL-23R was blocked by anti-IL-23R Ab or in the presence of excessive amounts of exogenous IL-23. We conclude that the balance between the enhancing and inhibitory effects of gd T cells is regulated by their level of IL-23R expression. The expression of variable IL-23R levels allows gd T cells to have different regulatory effects on adaptive immune responses, conceivably as a result of ab and gd T cells competing for IL-23.
L ymphocytes expressing gd TCR play a role in the regulation of inflammatory processes associated with infections, tumors, and autoimmunity (1) (2) (3) (4) (5) (6) . Studies have shown that gd T cells can either enhance (7) (8) (9) or inhibit (2, (10) (11) (12) an adaptive immune response, and that gd T cell subsets expressing distinct TCRs show functional diversity (13) (14) (15) (16) . Recent studies have shown that the regulatory effect of gd T cells is not a stable feature but fluctuates with gd T cell activation status (17, 18) . The mechanisms by which gd T cells enhance or inhibit an adaptive immune response are incompletely understood, and a better understanding of the flexible regulatory effect of gd T cells should facilitate the development of gd T cell-targeted immunotherapies for related diseases.
In this study, to define the mechanism by which gd T cells regulate the autoimmune response, we examined whether the enhancing and inhibitory effects of gd T cells can be predicted based on the presence of specific biomarkers. By comparing the enhancing or suppressive activities of gd T cells activated to different extents or by different pathways, we found that the IL-23R was such a marker. Our results showed that IL-23R expression differed between gd and ab T cells, that levels of surfaceexpressed IL-23R were different in gd T cells activated to different extents, and that Vg4 + gd T cells and Vg1 + gd T cells differed greatly in IL-23R expression. Functional studies showed that the suppressive effect of gd T cells was positively correlated with levels of IL-23R expression, both in vitro and in vivo. Manipulation of IL-23R function on gd T cells using an anti-IL-23 Ab or by the presence of high amounts of exogenous IL-23 reduced gd T cell suppressive activity. We also showed that gd T cells express the IL-23R in a biphasic fashion, as partially activated gd T cells; but those gd T cells that were either not activated or highly activated did not express the IL-23R. Weak activation of previously nonactivated gd T cells led to IL-23R expression, whereas exposure to a combination of stimulants resulted in highly activated gd T cells with no IL-23R expression. We conclude that the enhancing and inhibitory effects of gd T cells are switched on and off during gd T cell activation, and that the expression of variable IL-23R levels allows gd T cells to exert different regulatory effects on the adaptive immune response, conceivably by competition between ab and gd T cells for IL-23.
Materials and Methods

Animals and reagents
Female C57BL/6 (B6) mice were purchased from The Jackson Laboratory (Bar Harbor, ME), and were housed and maintained in the animal facilities of the University of Southern California. Institutional approval was obtained and institutional guidelines regarding animal experimentation followed. Recombinant murine IL-23 and IL-12 were purchased from R&D Systems (Minneapolis, MN). FITC-or PE-conjugated Abs against mouse IFN-g, IL-17, abTCR, gdTCR, and anti-mouse Vg1/Vg4 were purchased from BioLegend (San Diego, CA). PE-anti-IL-23R Ab was purchased from R&D Systems.
Immunization procedure and in vitro stimulation of in vivo primed T cells B6 mice were immunized s.c. over 6 spots at the tail base and on the flank with 200 ml emulsion containing 150 mg of the uveitogenic peptide IRBP 1-RPMI 1640 medium (Cellgro, Manassas, VA) containing 10% FCS were added to each well of a 6-well plate (Costar) and stimulated for 48 h with 10 mg/ml IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] in the presence of 1 3 10 7 irradiated syngeneic spleen cells as APCs in the presence of either IL-12 (Th1 polarized) or IL-23 (Th17 polarized; 10 ng/ml), and then activated T cell blasts were separated by Ficoll gradient centrifugation and cultured for another 72 h in the same medium used for stimulation without the peptide.
gd T cell preparation gd T cells were purified from IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] immunized B6 mice (5, 19, 20) . Nylon wool-enriched splenic T cells from immunized mice were incubated for 10 min at 4˚C with FITC-conjugated anti-mouse gd TCR or ab TCR Ab, then for 15 min at 4˚C with anti-FITC Microbeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). The cells were then separated into bound and nonbound on an autoMACS separator column (Miltenyi Biotec GmbH). The purity of the isolated cell as determined by flow cytometric analysis of PE-conjugated Abs against ab or gd T cells was .95%. Resting cells were harvested from this isolate after culture in cytokine-free medium for 5-7 d, when they showed downregulation of CD69 expression. Activated gd T cells were prepared by incubating the resting gd T cells with anti-gdTCR (GL3) and anti-CD28 Abs (2 mg/ml) for 2 d. syngeneic spleen cells. The activated T cell blasts were then separated by Ficoll gradient centrifugation and cultured in polarizing culture medium for 3 d; then cytoplasmic expression of IFN-g and IL-17 by the responder T cells was determined and cytokine levels in the culture supernatants assessed.
Assessment of in vitro effect
Cytokine assays
Enriched T cells (3 3 10 4 cells/well) from the draining lymph nodes and spleens were cultured at 37˚C for 48 h in 96-well microtiter plates with irradiated syngeneic spleen APCs (1 3 10 5 ) in the presence of IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ; then a fraction of the culture supernatant was assayed for IL-17 using ELISA kits (R&D Systems).
Intracellular staining and FACS analysis
For intracellular staining, T cells (2 3 10 5 in 100 ml PBS) were incubated for 4 h with 50 ng/ml PMA, 1 mg/ml ionomycin, and 1 mg/ml brefeldin A (Sigma-Aldrich), then were washed, fixed, permeabilized overnight with Cytofix/Cytoperm buffer (eBioscience), intracellularly stained with Abs against IFN-g and IL-17, and analyzed on a FACSCalibur flow cytometer.
Statistical analysis
Experiments were repeated at least twice, usually three or more times. Experimental groups were typically composed of four mice. The figures show data from a representative experiment. Differences between the values for different groups were examined using the two-tailed t test.
Results
Biphasic expression of the IL-23R by gd T cells
We first measured numbers of IL-23R
+ gd T cells in naive and immunized mice. As shown in Fig. 1A , none of the gd T cells in naive B6 mice expressed appreciable amounts of the IL-23R, whereas this receptor was expressed by a high percentage (51.4%) of gd T cells from mice immunized with IRBP in CFA. We then examined IL-23R expression on gd T cells isolated from immunized B6 mice and cultured in cytokine-free medium for 5-10 d (resting cells). As shown in Fig. 1B , resting cultured gd T cells expressed the IL-23R, but activation by 48-h exposure to a combination of cytokines resulted in a marked decrease in IL-23R expression from 69% of cells to 8%. We also compared IL-23R expression by gd and ab T cells freshly isolated from naive and immunized mice, and found that it was expressed on 0.2% of ab T cells from naive mice and only 3-5% of ab T cells from immunized mice (Fig. 1C) , contrasting with expression on 50-60% of gd T cells from immunized mice (Fig. 1A) . Moreover, only a small percentage of resting cultured ab T cells expressed the IL-23R after 48-h activation by incubation with anti-CD3 Abs (increase from 2.7 to 6.1%; Fig. 1D ). A kinetic study (Fig. 1E, 1F) showed that resting gd T cells expressed high levels of IL-23R protein and mRNA, whereas 2 d after in vitro activation the IL-23R was undetectable and remained so for approximately a week, then gradually reappeared and was present at high levels for at least 18 d, the longest time tested, then was again lost on reactivation. Thus, cultured gd T cells expressed high IL-23R levels until they were exposed to a new activation signal after being rested.
Weakly activated gd T cells express the highest IL-23R levels
Our studies showed that cytokines, particularly IL-1, IL-7, and IL-23, are able to activate gd T cells; in addition, these cytokines have a synergistic effect on gd activation (Fig. 2) ; therefore, in some cases, we used a combination of three cytokines to activate gd T cells. After exposure of resting cultured gd T cells to a single cytokine (IL-1, IL-7, or IL-23) or a combination of all three, the activated cells expressed increased levels of CD69 ( Fig. 2A) and produced an increased amount of IL-17 ( Fig. 2B) , with the combination of three cytokines having a much greater effect. In contrast, although a single cytokine increased expression of IL-23R mRNA and surface IL-23R, the combination of all three resulted in almost complete loss of expression (Fig. 2C, 2D ). These results suggest that a combination of different cytokines has a synergistic effect on gd T cell activation, but only weakly activated gd T cells show increased IL-23R levels.
The suppressive effect is restricted to IL-23R + gd T cells
We then compared the regulatory effect of IL-23R + and IL-23R 2 gd T cells on the IL-17 + IRBP-specific T cell response in vitro. As we reported previously (17, 18) 
2/2 mice greatly affected the response of the ab T cells. As shown in Fig. 3A and 3B + gd T cells on the activation of both Th17 and Th1 IRBP-specific T cells. The responder T cells were stimulated with the immunization Ag (IRBP) under either Th1-polarizing (Fig. 4A) or Th17-polarizing (Fig. 4B ) conditions in the presence or absence of 2% gd T cells that had been previously left untreated or incubated with anti-IL-23R Ab. As shown in Fig. 4 , treatment with anti-IL-23R Ab reduced the suppressive activity of IL-23R + gd T cells on autoreactive Th17 cells (Fig. 4A, 4C ), but had only a very limited effect on autoreactive Th1 T cells (Fig. 4B) , supporting the idea that competition for IL-23 is the mechanism by which gd T cells suppress Th17 cells.
Addition of excess IL-23 inhibits the suppressive effect of IL-23R + gd T cells
We hypothesized that the suppressive effect might be caused by competitive binding of IL-23 by the earlier responding innate gd T cells, thus preventing the later responding IL-23-dependent ab T cells from reacting. In cell activation studies under Th17-polarized conditions, we previously found that the optimal concentration of IL-23 was 10 ng/ml. If the suppressive effect was due to IL-23 binding by innate gd T cells, it should be reduced if large amounts of IL-23 were provided. We therefore set up two parallel assay groups in which Th17 + T cell activation was performed under Th17-polarized conditions in the presence of either the standard concentration (10 ng/ ml) or a high concentration (40 ng/ml) of IL-23. As shown in Fig. 4D and 4E, addition of a high concentration of IL-23 markedly reduced the suppressive effect of IL-23R + gd T cells, suggesting that their ability to bind IL-23 is involved in their inhibitory effect.
IL-23R
+ , but not IL-23R 
FCS contains a factor or factors that support IL-23R expression by cultured gd T cells
As mentioned earlier, gd T cells from naive mice do not express the IL-23R, whereas resting cultured gd T cells express high IL-23R levels, even after prolonged culture in cytokine-free medium when the cells no longer express activation markers, such as CD69. To examine the possibility that factors in the culture me- dium other than added cytokines were able to maintain IL-23R expression on gd T cells, we tested whether FCS-containing medium helped retain IL-23R expression. As shown in Fig. 6 , when we cultured gd T cells for 4 d in cytokine-free medium containing 0-10% of heat-inactivated FCS, we found that gd T cells cultured in FCS-free medium no longer expressed the IL-23R, whereas those cultured in medium containing .3% FCS showed partial or complete retention of IL-23R expression, showing that FCS contains a factor or factors that support IL-23R expression by gd T cells.
Different IL-23R expression by Vg1 + and Vg4 + gd T cells A previous study in Listeria monocytogenes-infected mice showed that the IL-23R is expressed by gd T cells expressing TCR-Vg4 or TCR-Vg6, but not by gd T cells expressing TCR-Vg1 (21) . To determine whether the IL-23R-expressing gd T cells in B6 mice at 13 d after IRBP immunization belonged to different gd T cell subsets expressing different TCR segments, we compared IL-23R expression of Vg1 + and Vg4 + cells in naive and immunized mouse spleens. As shown in Fig. 7A , the IL-23R was expressed at high levels in Vg4 + cells from immunized mice, but only at low levels in these cells from naive mice, whereas Vg1 + cells from either naive or immunized mice expressed only low or very low levels. Similarly, as shown in Fig. 7B , when cultured in vitro, Vg1 + cells initially expressed the IL-23R at lower levels than Vg4 + cells, but on activation with either a cytokine mixture or anti-CD3 Abs, Vg1 + cells showed increased IL-23R expression, whereas Vg4 + cells showed a marked reduction in IL-23R expression.
Discussion
Although a regulatory effect of gd T cells on adaptive immunity has been repeatedly observed (15, (22) (23) (24) , knowledge of how these cells regulate the immune response is still limited, and the mechanisms by which they enhance an immune response in some cases, but inhibit it in others, remain largely obscure. gd T cell subsets expressing distinct gd TCR Vg segments have been found to show functional diversity (13) (14) (15) (16) . More recently, we showed that the regulatory effect of gd T cells fluctuates with their activation status (17, 18) . Examining the mechanism by which gd T cells exert enhancing or inhibitory effects on autoimmune responses, we previously showed that activated gd T cells differ greatly from nonactivated gd T cells in their regulatory effect (17, 25) . In this study, we found that IL-23R expression on gd T cells differed greatly from that on ab T cells, with a large percentage (∼50%) of gd T cells, but only a small percentage of ab T cells (3%), in the spleens of immunized mice expressing the IL-23R. Our in vitro studies showed that IL-23R expression was seen on gd T cells exposed to a single cytokine, which provides only a partial stimulatory effect, but not on highly activated gd T cells, such as those activated by multiple cytokines or anti-CD3 Abs. Both in vitro and in vivo functional tests showed that IL-23R + gd T cells had a strong suppressive effect, whereas IL-23R 2 gd T cells were far less suppressive when nonactivated and had an enhancing effect when highly activated. Because both nonactivated and highly activated gd T cells are IL-23R 2 , the function of the IL-23R 2 gd T cells is complex and would depend on their activation status (17) . We have determined factors that lead to increased expression of IL-23R on gd cells in immunized mice.
Our results show that a synergistic effect between CFA and pertussis toxin, rather than the immunizing autoantigen, has caused this alteration, and the expression of IL-23R on gd T cells directly correlates with the activation status of the latter cells. It appears that gd T cells can readily alter their regulatory activity in response to environmental factors. Given that IL-23 is an important growth factor for pathogenic IL-17-producing ab T (Th17) cells (21, (26) (27) (28) and that it is produced only in small amounts and only by myeloid cells activated by certain ligands (29, 30) , binding of IL-23 to the earlier responding innate gd T cells might have a significant impact on subsequent ab T cell responses. This idea was supported by experiments showing the suppressive effect was abolished by blockade of the IL-23R on gd T cells using anti-IL-23R Ab and attenuated in the presence of a high concentration of exogenous IL-23. In addition, IL-23R + gd T cells proliferated vigorously when added to responder ab T cells under Th17-polarized conditions (culture medium containing IL-23), whereas IL-23R 2 gd T cells proliferated only poorly. gd T cells can be activated by multiple pathways in the absence of TCR ligation (1, (31) (32) (33) (34) (35) . We have previously shown that gd T cells in mice with induced experimental autoimmune uveitis are not activated by the immunizing Ag, but by cytokines (20) . In this article, we showed that cultured gd T cells could be readily activated by exposure to various cytokines. The degree of activation of gd T cells after exposure to different stimulatory factors varied, as judged by expression of activation surface molecules (CD69, CD62L, and CD44) and the production of cytokines (IL-17, IFNg, and IL-22). A synergistic effect was seen when gd T cells were exposed to a combination of stimulatory factors. An inflammatory condition might result in partially or highly activated gd T cells. In a weak inflammatory environment, gd T cells might be modestly activated and become IL-23R + and gain inhibitory activity, whereas in strong inflammatory conditions or when larger amounts of proinflammatory cytokines are available, they might become highly activated, become IL-23R
2 , and lose inhibitory activity.
Our findings agree with a previous observation that IL-23-activated gd T cells show increased suppressive activity (1) and further support the notion that IL-23 plays a major role in modulating the regulatory activity of gd T cells on subsequently induced adaptive responses. We have observed that FCS contain factor(s) that helped retain IL-23R expression of cultured gd T cells, in that gd T cells cultured in FCS-free medium gradually lost surface IL-23R, whereas those cultured in medium containing .3% FCS showed partial or complete retention of IL-23R expression. To overcome potentially decreased cell viability of cultured cells in serum-free conditions, we have replaced 10% FCS in culture with a small amount (1%) of mouse serum. Remarkably, gd T cells survived much better in medium containing 1% mouse serum and the results repeated those obtained with cells cultured in serum-free medium (data not shown). These results further supported our conclusion that high FCS-containing media are able to retain gd T cell activation status.
We observed that Vg1 + and Vg4 + gd T cells differed significantly in IL-23R expression. For example, Vg4
+ , but not Vg1 + , gd T cells in immunized mice expressed the IL-23R in vivo, even though both cell populations were able to express it after anti-CD3 activation in vitro, suggesting that these two cell populations have different requirements or thresholds for activation. Further studies should clarify how differences in activation requirements contribute to the different dominance and regulatory effects of different gd T cell subsets in infections (36, 37) , tumors (6, 38) , and induced autoimmune diseases (39) . In this study, we observed that cultured resting gd T cells retained the IL-23R in the absence of additional stimulation by cytokines, and that FCS contained a factor or factors that are able to maintain IL-23R expression on gd T cells, suggesting that gd T cells grown in FCS-containing culture medium are constantly partially activated, even though they fail to express other activation markers, such as CD69. Expression of the IL-23R may represent an early biomarker for minimally activated gd T cells. It is likely that a large number of environmental factors are capable of causing gd T cell activation, and thus modulating the regulatory effects of gd T cells.
